Skip to main content
. 2024 Jul 2;12(7):734. doi: 10.3390/vaccines12070734

Figure 1.

Figure 1

SARS-CoV-2 serum-neutralizing geometric mean titers (GMTs) with 95% CIs against Omicron XBB.1.5 (a), BA.2.86 (b), and JN.1 (c) before and 1 month after vaccination with monovalent XBB.1.5-adapted BNT162b2 or bivalent BA.4/BA.5-adapted BNT162b2. Geometric mean fold rises (GMFRs) and 95% CIs from before vaccination to 1 month after vaccination are also shown. Results that were less than the lower limit of quantitation (LLOQ) were set to 0.5 × LLOQ. 1m = 1 month after vaccination; FFRNT = fluorescent focus reduction neutralization test; Pre = before vaccination.